Researchers at Rockefeller University say they have identified a regulatory circuit in the skin that helps keep the barrier stable by linking epidermal stem cells with Langerhans immune cells. The findings, published in Science, describe a mechanism that appears to fine-tune how the skin responds to microbes on the surface while preserving normal tissue renewal.
A built-in control system for the skin
According to the study summary, epidermal stem cells continuously produce the specialized skin cells that move upward to form the outer protective layer, while also maintaining a reserve of new stem cells. The newly described circuit connects these stem cells to the skin surface through Langerhans cells, which extend cellular projections across epithelial layers and relay signals between the two.
The researchers describe the system as acting like a rheostat, continuously adjusting the stem cells’ response to the environment. In the article, they say Langerhans cells detect signals from microbes on the skin surface and then use chemical messaging to tell stem cells whether to generate more stem cells or direct cells to differentiate.
What happens when the circuit is disrupted
In experiments described by the Rockefeller team, animals lacking Langerhans cells showed increased epidermal stem-cell proliferation and differentiation. The researchers also reported that a gene called Ptgs1 was uniquely enriched in Langerhans cells compared with other skin-resident immune cells. That gene codes for COX-1, an enzyme needed to produce prostaglandins, including PGE2.
The study summary says epidermal stem cells carry one prostaglandin receptor, EP4, which is specific for PGE2. When PGE2 levels were insufficient, stem-cell proliferation increased and their progeny did not fully complete differentiation before reaching the skin surface. The result, the researchers said, was weaker barrier function, unusual responses to benign bacteria, reduced antimicrobial peptide production and a shift in the native skin microbiota.
Why the finding matters for biomedical science
The researchers say the presence of Langerhans cells prevented those negative outcomes by adjusting COX-1 and PGE2 production in response to surface microbiota. The study suggests that skin immunity is not only about defending against pathogens, but also about maintaining a balanced environment that supports healthy tissue renewal. The team also said it now wants to explore how this system responds to pathogenic bacteria and inflammation.
The work adds to a growing picture of how immune cells can do more than fight infection. In this case, they appear to help coordinate the skin’s day-to-day maintenance, ensuring that the barrier stays both resilient and properly renewed.
Read more from the original source at News-Medical.
Photo source: AI-generated or edited image
